Clinical Trials Browser

Phase 2 × Neurotoxicity Syndromes × Rituximab × Clear all

NCT01399372 2023-07-20

Rituximab, Methotrexate, Vincristine Sulfate, Procarbazine Hydrochloride, and Cytarabine With or Without Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma

Phase 2 Completed

91 enrolled 17 charts

Lymphoma, Radiation Injuries, Neurotoxicity Syndromes